ArticleExperimental & molecular medicine2022

MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis.

Junqing Gan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.